Results 11 to 20 of about 476 (86)
Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends
Background. Despite an association between operator volumes and procedural success, there remains an incomplete understanding of the contemporary utilization and procedural volumes for mitral valve transcatheter edge-to-edge repair (MTEER).
Kris Kumar +9 more
doaj +1 more source
Background Limited data are available about clinical outcomes and residual mitral regurgitation (MR) after transcatheter edge‐to‐edge repair in the large Asian‐Pacific cohort.
Shunsuke Kubo +22 more
doaj +1 more source
Transcatheter Edge-to-edge Repair of Severe Tricuspid Regurgitation
Despite the increasing knowledge of the long-term adverse consequence of severe tricuspid regurgitation (TR), most patients with moderate- to-severe TR are still treated conservatively because of the high risk of surgery.
Shu-I Lin +7 more
doaj +1 more source
Transcatheter mitral valve repair for primary mitral regurgitation
The landscape of transcatheter mitral valve repair devices continues to expand, with many technologies undergoing investigation in patients with primary mitral regurgitation (MR).
Rowa H. Attar +2 more
doaj +1 more source
Short‐Term Effects of Different Transcatheter Edge‐to‐Edge Devices on Mitral Valve Geometry
Background Short‐term effects on mitral valve (MV) anatomy after transcatheter edge‐to‐edge repair using the PASCAL system remain unknown. Precise quantification might allow for an advanced analysis of predictors for mean transmitral gradients.
Sebastian Rosch +14 more
doaj +1 more source
Mitral transcatheter edge-to-edge repair (MTEER) is the first transcatheter technique for mitral valve repair (MVR) in patients with severe mitral regurgitation (MR) who are considered at high risk for surgical intervention.
Khaled Al Khodari +3 more
doaj +1 more source
Mitral Transcatheter Edge‐to‐Edge Repair in Younger Adults
Background Younger patients aged ≤65 years who have significant comorbidities deemed unsuitable for surgery, transcatheter edge‐to‐edge repair (TEER) may serve as an alternative, although the long‐term outcomes remain uncertain.
Yuchao Guo +15 more
doaj +1 more source
In 2022, the Food and Drug Administration approved a second mitral transcatheter edge-to-edge repair device for the treatment of primary mitral regurgitation (PASCAL Precision Transcatheter Valve Repair System, Edwards Lifesciences, Irvine, CA).
Santiago Garcia, MD +8 more
doaj +1 more source
Bioinspired passive flow routing mitigates thrombosis in cardiovascular devices by redirecting a small fraction of forward flow into stagnation‐prone regions. Inspired by avian alula and aircraft slat mechanisms, strategically placed routing channels restore washout around mechanical heart valves, reducing low‐shear exposure by four orders of magnitude
Yevgeniy Kreinin +8 more
wiley +1 more source
The challenges of bioprosthetic heart valves (BHV) with respect to calcification, infection, and poor durability are tackled by surface engineering of hyperbranched poly‐L‐lysine (HBPL), providing a translational solution to improve long‐term valve performance.
Pai Peng +7 more
wiley +1 more source

